Research
Metabolic adaptation
Retatrutide achieves an 82.4% relative reduction in hepatic fat and normalizes liver fat in 86% of patients.
Retatrutide may be beneficial for patients with fatty liver disease.
StrongSupportsmedium confidence
Retatrutide demonstrates potent efficacy in resolving metabolic dysfunction-associated steatotic liver disease, achieving an 82.4% relative reduction in hepatic fat and normalization of liver fat in 86% of patients.
Why this rating
Based on Phase 2 clinical data from a controlled study.
Source
Triple Hormone Receptor Agonism: The Role of Retatrutide in Addressing Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Comprehensive Review
Ashwin A. Pillai et al. · Cardiology in Review · 2026
DOI 10.1097/crd.0000000000001310
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →